≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other diseases of appendix

DOID EFO Endpoint Browser PheWeb

K11_OTHAPPEND

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K38
  • Hospital discharge: ICD-9 — 543
  • Hospital discharge: ICD-8 — 543
  • Cause of death: ICD-10 — K38
  • Cause of death: ICD-9 — 543
  • Cause of death: ICD-8 — 543

2 out of 7 registries used, show all original rules.

419

4. Check minimum number of events

None

419

5. Include endpoints

None

419

6. Filter based on genotype QC (FinnGen only)

419

Control definitions (FinnGen only)

Control exclude
K11_APPENDIX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K35-K38
Name in latin
Alii morbi appendicis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3360 2099 1235
Only index persons 2823 1812 1011
Unadjusted period prevalence (%)
Whole population 0.05 0.06 0.03
Only index persons 0.06 0.07 0.04
Median age at first event (years)
Whole population 37.74 37.44 37.89
Only index persons 33.98 34.08 33.82

-FinnGen-

Key figures

All Female Male
Number of individuals 419 286 133
Unadjusted period prevalence (%) 0.09 0.10 0.06
Median age at first event (years) 37.42 35.73 41.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
377
Matched controls
3772
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
54301
ICD-8 Finland
Other diseases of appendix, Stercolithium appendicis
+∞
74.5
69
*
K38.9
ICD-10 Finland
Disease of appendix, unspecified
+∞
73.4
68
*
JEA01
NOMESCO Finland
Laparoscopic appendectomy
76.7
57.4
64
10
K38.8
ICD-10 Finland
Other specified diseases of appendix
+∞
53.4
50
*
54309
ICD-8 Finland
Other diseases of appendix, Unspecified
+∞
52.3
49
*
54308
ICD-8 Finland
Other diseases of appendix, Alii definiti
+∞
41.4
39
*
5439X
ICD-9 Finland
Other diseases of appendix, Other and unspecified diseases of appendix
+∞
40.3
38
*
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
+∞
25.3
24
*
K38.1
ICD-10 Finland
Appendicular concretions
+∞
24.2
23
*
6421
FHL
Appendicectomy
9.2
19.0
40
48
54300
ICD-8 Finland
Other diseases of appendix, Mucocele appendicis
+∞
16.8
16
*
JEA00
NOMESCO Finland
Appendectomy
8.8
15.9
34
42
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
+∞
13.6
13
*
54003
ICD-8 Finland
Acute appendicitis, Cum abscessu
+∞
12.6
12
*
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
31.1
11.7
15
5
K38.0
ICD-10 Finland
Hyperplasia of appendix
+∞
11.5
11
*
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
45.9
7.7
9
*
JAH01
NOMESCO Finland
Laparoscopy
4.2
7.6
28
71
K37
ICD-10 Finland
Unspecified appendicitis
81.6
7.4
8
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
30.6
7.2
9
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.8
166
1146
54399
ICD-8 Finland
NA
+∞
6.3
6
*
K36
ICD-10 Finland
Other appendicitis
+∞
6.3
6
*
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
+∞
6.3
6
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
27.2
6.2
8
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
88
404
2.49
11.90
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
81
372
2.46
10.88
4.0
4.0
ug/l
3.8
20.7
0.82
65
300
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
11
18
6.25
6.46
3.6
3.5
nmol/l
55.9
71.7
0.84
11
18
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
15
34
4.54
6.28
4.1
3.1
nmol/l
2.6
3.5
0.61
15
34
(3019225) pH of Specimen
61
318
2.07
5.93
4.0
4.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
70
402
1.89
5.16
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
149
1080
1.59
4.69
2.6
2.5
u/l
65.9
57.2
0.26
137
997
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
45
235
2.02
4.36
1.4
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
227
1829
1.53
4.35
7.7
6.1
umol/l
11.0
10.8
0.11
220
1734
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
200
1583
1.50
4.08
4.9
3.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
42
3.41
4.08
1.4
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
30
141
2.21
3.81
3.9
2.8
u/ml
788.2
1234.4
0.14
24
117
(3044640) Blood type and Crossmatch panel - Blood
144
1077
1.51
3.79
3.2
2.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
40
212
1.98
3.73
2.4
2.4
u/ml
26.5
68.9
1.08
40
203
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
47
3.05
3.44
1.4
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
177
1406
1.45
3.36
2.4
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
84
2.45
3.28
2.8
2.5
u/ml
0.5
0.4
—
9
49
(3013826) Glucose [Moles/volume] in Serum or Plasma
235
1981
1.42
3.15
6.6
4.3
mmol/l
6.7
6.7
0.19
229
1856
(3013650) Neutrophils [#/volume] in Blood by Automated count
235
1987
1.42
3.07
8.8
8.9
e9/l
4.2
4.0
0.70
214
1741
(3024561) Albumin [Mass/volume] in Serum or Plasma
182
1474
1.41
3.02
5.7
4.4
g/l
36.4
35.7
0.88
168
1366
(3013707) Erythrocyte sedimentation rate by Westergren method
297
2624
1.45
3.00
4.3
4.1
mm/h
12.2
12.1
0.04
278
2406
(3031040) Bacteria [#/volume] in Urine by Automated count
261
2255
1.42
2.97
5.0
4.5
e6/l
1699.0
3889.7
—
7
40
(3036481) Cortisol [Moles/volume] in Serum or Plasma
49
303
1.70
2.84
2.1
2.0
nmol/l
375.8
365.3
0.13
44
282
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
304
2711
1.44
2.81
8.9
7.4
u/l
77.1
78.5
0.28
282
2537
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
42
2.91
2.77
1.3
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
109
816
1.45
2.75
2.8
2.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
167
1354
1.39
2.68
9.1
8.7
inr
1.2
1.2
0.46
55
397
(3037121) Protein [Mass/volume] in Urine
23
113
2.10
2.67
1.7
3.2
g/l
0.1
0.1
—
7
38
(3018010) Neutrophils/100 leukocytes in Blood
195
1623
1.38
2.66
6.0
5.6
%
57.4
57.1
0.09
188
1511
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
22
107
2.11
2.62
1.9
1.9
g/l
38.6
37.7
0.23
17
93
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
162
1314
1.38
2.57
3.6
3.7
ng/l
33.6
32.3
0.04
111
911
(42870588) Differential panel, method unspecified - Blood
142
1129
1.39
2.53
6.0
5.7
—
—
—
0
0
(4034850)
23
118
2.00
2.40
9.8
8.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
58
2.46
2.39
1.4
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
195
1645
1.35
2.36
6.4
5.8
%
27.4
28.0
0.37
186
1523
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
21
105
2.05
2.35
1.9
1.6
—
200.0
—
0
7
(4035726)
49
320
1.60
2.32
1.4
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
44
280
1.64
2.31
1.8
2.5
g/l
66.3
67.1
0.23
38
257
(3048689) Calprotectin [Mass/mass] in Stool
61
420
1.53
2.31
2.4
2.3
ug/g
167.1
129.3
0.54
48
321
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
187
1574
1.34
2.27
8.5
5.3
mmol/l
1.2
1.2
0.30
164
1431
(40768443) Skin Pathology biopsy report
29
165
1.81
2.25
1.0
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
121
1.95
2.25
1.9
2.0
g/l
3.4
3.2
0.33
18
97
(3013512) EKG study
126
1000
1.37
2.24
3.6
3.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
201
1716
1.33
2.19
9.8
6.3
mmol/l
1.2
1.2
0.24
170
1457
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
24
3.38
2.19
1.9
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
14
4.33
2.16
1.7
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
67
478
1.48
2.15
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
198
1697
1.32
2.06
3.6
3.8
estimate
0.0
0.0
0.00
39
328
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
356
1.53
2.03
1.4
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
63
2.26
2.03
1.6
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
183
1558
1.31
1.98
6.1
5.7
%
0.7
0.7
0.56
176
1439
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
27
3.00
1.94
1.4
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
203
1758
1.30
1.92
5.6
5.6
e9/l
1.8
1.9
0.66
180
1558
(3037467) Urinalysis macro (dipstick) panel - Urine
263
2361
1.31
1.88
4.7
4.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
47
321
1.52
1.86
3.1
2.5
u/l
73.2
46.8
0.30
40
261
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
17
3.56
1.84
3.0
4.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
12
4.20
1.83
1.8
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
130
1066
1.32
1.82
3.1
3.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
131
1.80
1.81
1.9
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
131
1.80
1.81
1.9
2.0
g/l
4.0
3.7
0.74
18
95
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
131
1.80
1.81
1.9
2.0
g/l
7.8
7.6
0.21
18
101
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
296
2707
1.32
1.81
4.3
4.0
pmol/l
14.9
14.7
0.43
269
2456
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
508
1.40
1.72
3.4
2.8
e6/l
4.8
2.9
0.42
37
262
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
13
3.88
1.72
1.8
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
196
1709
1.28
1.69
3.8
3.8
estimate
0.0
0.0
0.50
41
313
(3019069) Monocytes/100 leukocytes in Blood
186
1614
1.27
1.66
6.8
6.0
%
8.4
8.6
0.29
179
1503
(3021601) Nitrite [Presence] in Urine by Test strip
195
1704
1.27
1.64
5.2
5.1
estimate
0.0
0.0
0.00
40
330
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
128
1.76
1.64
1.7
2.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
185
1608
1.27
1.62
6.3
5.7
%
2.9
2.8
0.21
175
1484
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
72
549
1.38
1.62
3.2
2.6
e6/l
1.1
1.0
0.09
39
300
(4268621)
8
32
2.53
1.60
3.0
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
26
2.72
1.58
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
122
1.76
1.57
1.7
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
113
926
1.30
1.57
3.8
4.1
estimate
0.0
0.0
0.69
39
325
(3045424) Erythrocytes [Presence] in Urine
12
57
2.14
1.56
1.1
1.4
—
—
—
0
0
(4024509)
8
33
2.45
1.54
1.3
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
196
1724
1.26
1.53
5.6
5.6
e9/l
0.0
0.0
0.08
168
1493
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
86
1.89
1.52
1.6
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
58
2.10
1.50
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
163
1.63
1.50
21.3
8.8
—
—
—
0
0
(4281824)
9
38
2.40
1.46
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.46
1.1
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
230
1.52
1.44
3.6
2.7
e9/l
4.2
3.9
0.34
27
177
(3013115) Eosinophils [#/volume] in Blood
201
1782
1.25
1.44
5.7
5.8
e9/l
0.2
0.2
0.87
173
1579
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
16
3.15
1.44
1.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
171
1489
1.25
1.44
2.6
2.2
nmol/l
77.3
78.1
0.13
154
1318
(3023368) Bacteria identified in Blood by Culture
108
890
1.29
1.43
4.2
4.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
194
1714
1.25
1.43
5.7
5.6
e9/l
0.6
0.6
0.34
166
1488
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
46
2.20
1.41
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
53
2.10
1.39
1.7
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
421
1.38
1.39
1.6
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
26
167
1.59
1.38
3.2
2.8
e6/l
0.1
0.2
1.02
26
162
(3004588) Protein electrophoresis panel - Serum or Plasma
35
241
1.49
1.38
1.9
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
104
858
1.28
1.37
5.7
3.5
%
93.0
93.3
0.03
104
839
(3011397) Hemoglobin [Presence] in Urine by Test strip
96
785
1.29
1.35
3.5
3.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
90
1.81
1.35
1.6
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
55
415
1.37
1.34
29.1
21.2
inr
1.5
1.3
—
10
53
(3030467) Casts [#/volume] in Urine by Automated count
111
926
1.27
1.33
3.5
2.9
e6/l
0.2
0.5
2.07
84
691
(3016018) Differential panel - Cerebral spinal fluid
6
24
2.52
1.31
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
256
2346
1.23
1.30
4.0
3.1
u/l
44.4
47.1
0.27
242
2189
(3002582) Erythrocytes [#/volume] in Urine
119
1004
1.26
1.30
3.7
3.1
e6/l
51.3
98.1
0.30
92
771
(3045414) Leukocytes [Presence] in Urine
23
146
1.61
1.29
1.5
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
342
3243
1.30
1.26
4.8
4.8
mu/l
1.9
2.3
0.56
315
2955
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
36
2.25
1.25
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
56
429
1.35
1.25
1.3
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
139
1200
1.24
1.23
4.5
3.5
e6/l
24.0
76.0
3.46
98
842
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
49
2.07
1.23
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
49
2.07
1.23
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
49
2.07
1.23
1.3
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
86
703
1.28
1.21
2.5
2.4
e6/l
7.0
6.5
0.08
72
622
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
15
86
1.77
1.20
1.7
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
80
649
1.29
1.20
4.5
3.9
ng/l
227.1
251.5
0.06
57
504
(3023419) Bacteria identified in Sputum by Culture
8
38
2.13
1.19
1.6
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.3
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
104
874
1.25
1.17
5.9
6.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
191
1.50
1.17
1.5
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
34
0.00
1.16
0.0
1.2
—
383.8
—
0
29
(3037522) Nuclear Ab [Titer] in Serum
60
470
1.32
1.16
1.3
1.3
titre
333.3
498.3
—
9
105
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
39
2.07
1.16
1.9
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
49
373
1.36
1.14
1.7
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
105
886
1.25
1.14
1.8
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
201
1.48
1.13
1.2
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
91
756
1.26
1.13
1.2
1.2
u/ml
2.8
1.8
0.17
18
211
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
21
2.40
1.09
4.4
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
41
1.97
1.09
1.6
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
138
1207
1.21
1.06
3.6
3.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
67
1.81
1.05
3.7
3.7
%
58.2
56.8
0.09
12
67
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
90
1.69
1.05
1.1
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
541
1.28
1.05
1.9
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
348
3329
1.27
1.04
15.6
12.5
ml/min/173m2
81.8
80.5
0.55
310
2732
(3011648) Oxygen content in Venous blood
5
22
2.29
1.03
3.2
2.1
%
10.4
12.0
—
5
22
(3032773) Endomysium IgG Ab [Titer] in Serum
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
436
1.30
0.99
5.1
4.4
%
34.3
32.4
0.57
46
282
(3015377) Calcium [Moles/volume] in Serum or Plasma
139
1225
1.20
0.98
3.9
3.4
mmol/l
2.4
2.4
0.23
117
1069
(3019150) Specific gravity of Urine by Refractometry
90
760
1.23
0.97
3.7
4.1
kg/l
1.0
1.0
0.09
13
100
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
54
1.87
0.97
1.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
362
3487
1.28
0.96
16.9
13.7
mg/l
22.2
22.2
0.00
307
2750
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
93
1.64
0.95
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
37
1.91
0.94
1.4
3.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
372
3600
1.30
0.91
19.6
15.5
mmol/l
139.7
139.7
0.10
367
3505
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
130
1148
1.19
0.89
3.4
3.1
u/l
33.4
31.9
0.19
124
1095
(3003396) Base excess in Arterial blood by calculation
46
363
1.30
0.87
15.1
6.9
mmol/l
1.0
1.4
0.31
36
292
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
1.3
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
214
1.38
0.85
1.5
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
383
3727
1.32
0.84
12.0
10.4
u/l
26.8
25.6
0.66
371
3602
(3021788) Differential panel - Synovial fluid
10
57
1.77
0.84
1.7
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
148
1329
1.18
0.83
4.0
3.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
122
1081
1.18
0.80
2.3
2.1
u/l
183.2
179.7
0.03
117
1019
(3019309) Folate [Moles/volume] in Red Blood Cells
76
645
1.22
0.80
1.7
1.7
nmol/l
1229.1
1196.0
0.13
56
474
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
66
1.68
0.79
3.4
3.2
e9/l
4.9
4.4
0.24
11
66
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
66
1.68
0.79
2.2
1.8
u/l
5249.6
734.5
—
5
21
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
66
1.68
0.79
2.6
4.2
mg/l
28.8
25.9
—
6
42
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
96
0.52
0.79
1.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.3
—
1.0
—
0
27
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
28
0.00
0.76
0.0
1.3
—
36554.1
—
0
14
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
100
1.52
0.74
3.0
2.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
39
1.81
0.73
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.3
2.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
195
1.36
0.71
4.7
3.7
mmol/l
2.0
2.0
0.00
21
145
(3052851) Hemolysis interference index of Serum or Plasma
15
101
1.50
0.71
3.1
3.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
41
1.72
0.70
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
110
1.47
0.69
1.1
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
371
3611
1.24
0.69
19.6
15.6
mmol/l
4.0
4.0
0.12
366
3511
(3044290) Cell count panel - Cerebral spinal fluid
9
59
1.54
0.68
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
191
0.67
0.68
1.8
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
76
656
1.19
0.68
3.1
2.6
mosm/kgh2o
553.5
540.1
0.20
66
562
(1761868) Lipid panel - Serum or Plasma
114
1267
0.86
0.66
2.8
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
78
677
1.19
0.66
1.5
1.4
g/l
1.9
2.5
2.16
45
418
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
234
1.30
0.65
1.1
1.2
iu/ml
108.1
157.8
—
10
93
(3009508) Creatinine [Moles/volume] in Urine
96
1078
0.86
0.64
3.1
3.1
mmol/l
6.9
7.3
0.38
79
890
(3012516) Albumin [Mass/volume] in Urine
90
1014
0.86
0.63
3.2
3.3
mg/l
710.2
256.4
0.29
51
619
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
382
1.23
0.61
1.7
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
51
1.58
0.60
1.5
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
102
913
1.15
0.60
2.7
2.6
umol/l
330.4
6204.9
3.76
94
799
(3024263) Appearance of Synovial fluid
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
64
1.58
0.59
2.2
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
477
1.20
0.59
1.6
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
33
265
1.27
0.59
2.7
4.0
%
0.7
0.6
—
8
58
(3051611) Lipemic interference index of Serum or Plasma
6
35
1.72
0.58
2.5
2.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
34
275
1.26
0.57
3.8
4.2
%
0.2
0.2
0.05
11
80
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
111
1003
1.15
0.57
2.6
3.0
ng/l
1208.6
1112.6
0.09
98
839
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
133
1.37
0.56
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.2
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
37
1.63
0.55
1.5
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.2
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
387
1.21
0.55
1.8
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
96
1064
0.87
0.54
3.9
4.0
mg/mmol
3.7
8.3
1.89
57
638
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
91
1.44
0.53
4.5
2.1
%
93.8
91.5
0.11
13
86
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
65
567
1.17
0.53
1.6
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
74
653
1.16
0.53
1.2
1.3
iu/ml
29.4
37.9
0.21
23
222
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
152
1409
1.12
0.52
2.1
1.9
pmol/l
105.8
96.1
1.18
80
690
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
63
1.44
0.52
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
36
297
1.23
0.52
3.8
4.1
%
1.5
0.9
0.55
12
90
(3020891) Body temperature
17
126
1.36
0.52
6.1
3.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
118
1.37
0.51
1.6
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
28
344
0.80
0.50
1.3
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
163
1522
1.12
0.49
11.5
9.3
e9/l
0.0
0.0
0.38
131
1258
(4306422)
7
45
1.56
0.49
1.6
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
99
898
1.13
0.48
3.7
2.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
47
1.50
0.48
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
89
803
1.14
0.47
1.6
1.5
nmol/l
21.1
22.2
0.25
74
678
(3025159) Blasts/100 leukocytes in Blood
32
264
1.23
0.47
3.9
4.2
%
0.2
0.1
—
10
69
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
48
1.47
0.47
1.4
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
74
662
1.14
0.45
3.1
2.8
mmol/l
2.4
2.5
1.43
66
577
(3022621) pH of Urine by Test strip
26
211
1.25
0.45
3.7
2.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
393
3873
1.24
0.44
24.6
20.2
e9/l
254.7
253.7
0.12
383
3776
(36660697) Celiac disease serology panel - Serum
30
248
1.23
0.44
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
159
1491
1.11
0.44
2.9
2.6
ug/l
143.8
111.9
0.45
145
1358
(4010399)
30
249
1.22
0.43
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
194
1.25
0.43
1.4
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
56
1.44
0.43
2.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
158
1.28
0.42
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
57
1.41
0.42
2.4
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
13
96
1.37
0.42
4.5
5.9
mmol/l
1.0
1.1
—
8
87
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
71
637
1.14
0.42
4.4
4.1
%
20.8
21.7
0.18
36
282
(3019060) Gas panel - Arterial blood
25
204
1.24
0.41
5.4
4.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
393
3876
1.22
0.41
24.5
20.1
e12/l
4.4
4.5
1.60
384
3771
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
428
1.16
0.41
6.5
7.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
56
495
1.15
0.41
1.9
1.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.1
—
150.6
—
0
17
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
393
3877
1.22
0.40
24.5
20.2
e9/l
6.5
6.6
0.50
383
3770
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
12.1
—
800.6
—
0
18
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
14.6
—
1362.1
—
0
18
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
80
726
1.13
0.40
1.5
1.7
pmol/l
192308161.3
446.9
0.79
65
602
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
35
1.43
0.39
2.0
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
33
280
1.19
0.39
3.7
3.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
91
834
1.12
0.38
2.2
2.0
mg/l
3.3
3.2
0.04
78
703
(3041096) Erythrocytes [Presence] in Urine by Automated
102
943
1.11
0.37
3.6
3.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
10
72
1.40
0.37
1.1
1.1
e6/l
102.2
3.1
—
5
55
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
223
0.80
0.36
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
90
1.34
0.36
1.8
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
108
1.31
0.35
1.6
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
239
2476
0.92
0.35
3.7
3.8
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.0
1.2
nmol/l
0.5
0.6
—
6
38
(3042631) Mycobacterium sp identified in Specimen
6
44
1.37
0.34
3.8
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
85
782
1.11
0.34
3.7
4.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
191
1.22
0.34
1.7
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
91
1.33
0.34
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
91
1.33
0.34
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
133
0.75
0.34
1.2
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
30
257
1.18
0.33
22.9
7.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
47
1.28
0.32
2.2
2.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
119
1.27
0.32
2.3
2.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
52
1.35
0.31
2.0
2.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
53
1.33
0.31
2.7
2.0
%
71.3
61.6
—
7
53
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
75
1.34
0.30
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
84
779
1.10
0.29
2.1
1.6
mg/l
2.4
1.1
0.48
63
602
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
62
566
1.11
0.29
1.3
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
31
270
1.16
0.29
3.7
2.8
e9/l
64.5
72.3
0.99
26
206
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
85
1.30
0.28
1.5
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
340
3456
0.91
0.27
4.4
4.5
mmol/l
1.5
1.5
0.19
323
3190
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
71
0.70
0.26
2.2
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
151
1.20
0.25
5.8
3.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
105
1.25
0.25
1.7
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
53
485
1.11
0.25
3.0
2.2
g/l
2.3
2.3
0.03
47
443
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
332
3264
1.08
0.24
5.4
5.9
mmol/mol
39.2
39.8
0.77
302
3045
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
126
0.79
0.24
1.5
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
83
0.72
0.24
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
115
1.22
0.24
3.1
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
40
1.25
0.22
10.4
4.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
41
1.22
0.22
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
41
1.22
0.22
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
33
296
1.12
0.22
2.2
2.4
ug/l
11.2
6.8
0.59
27
261
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
343
3477
0.93
0.22
4.5
4.5
mmol/l
4.8
4.8
0.10
323
3233
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
42
1.19
0.21
6.2
1.4
pg
34.0
33.0
—
5
42
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
0.9
—
0
5
(4198724)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
43
1.16
0.21
1.4
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
32
288
1.12
0.20
6.4
3.4
mmol/l
1.8
2.4
0.49
27
230
(3035285) Chloride [Moles/volume] in Venous blood
6
48
1.25
0.20
2.2
2.4
mmol/l
106.5
105.3
—
6
48
(3041354) Potassium [Moles/volume] in Venous blood
6
48
1.25
0.20
2.2
2.4
mmol/l
3.8
4.0
—
6
48
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
49
1.23
0.20
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
50
1.20
0.20
2.7
1.7
—
—
—
0
0
(1002224) Polysomnography panel
14
165
0.84
0.19
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
53
1.13
0.18
1.0
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
346
3418
1.07
0.18
4.5
4.6
mmol/l
5.9
5.9
0.37
320
3117
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
58
1.21
0.18
1.4
1.7
pmol/l
231.1
231.4
—
7
52
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
68
1.18
0.16
3.1
2.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
8
72
1.11
0.16
6.6
3.2
mmol/l
7.9
7.7
—
8
72
(3024928) Oxygen saturation in Venous blood
8
72
1.11
0.16
2.5
2.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
83
1.21
0.15
1.2
1.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
32
294
1.10
0.15
6.5
3.4
kpa
5.6
5.8
0.73
32
287
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
82
1.10
0.15
1.9
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
45
421
1.08
0.14
9.4
5.2
mmol/l
1.0
1.0
0.68
40
389
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
83
1.09
0.14
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
86
0.81
0.14
4.1
4.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
90
0.77
0.14
1.0
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
8
97
0.82
0.14
2.1
2.1
mg/l
11.7
11.6
—
8
89
(3024354) Oxygen [Partial pressure] in Venous blood
27
248
1.09
0.13
6.1
2.7
kpa
4.4
4.4
0.08
27
240
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
287
1.09
0.13
2.5
2.8
ml/min/173m2
66.5
65.5
0.05
11
122
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
37
346
1.08
0.12
3.1
3.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
114
1.14
0.12
1.6
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
972
0.96
0.11
1.8
1.6
mmol/l
1.3
1.4
0.23
86
823
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
178
0.89
0.11
2.3
2.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
352
3547
0.95
0.11
4.9
5.0
mmol/l
2.8
2.8
0.20
333
3266
(3009542) Hematocrit [Volume Fraction] of Blood
314
3169
0.96
0.10
18.4
14.4
%
39.7
40.0
0.30
224
2296
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
36
340
1.06
0.09
1.5
1.4
—
—
—
0
0
(44806118)
5
46
1.09
0.09
1.4
1.8
—
—
—
0
0
(44790049)
5
46
1.09
0.09
1.4
1.8
—
—
—
0
0
(44790047)
5
46
1.09
0.09
1.4
1.8
—
—
—
0
0
(44790048)
5
46
1.09
0.09
1.4
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
61
0.82
0.08
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
31
293
1.06
0.08
1.7
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
104
1065
0.97
0.08
4.5
3.8
ph
7.4
7.4
0.45
25
195
(3014051) Protein [Presence] in Urine by Test strip
8
74
1.08
0.07
2.0
2.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
54
521
1.04
0.07
3.1
2.3
umol/l
12.9
13.3
0.12
49
477
(40760888) Immunoglobulin light chains.free panel - Serum
9
84
1.07
0.07
2.7
4.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
218
2155
1.02
0.07
2.9
2.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
90
0.89
0.07
1.8
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
90
0.89
0.07
1.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
90
0.89
0.07
1.8
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
367
3652
1.04
0.06
15.5
12.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
315
1.05
0.06
2.0
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
14
152
0.92
0.06
1.6
2.3
u/l
35.5
38.1
0.20
14
136
(40768793) Breast Pathology biopsy report
12
109
1.10
0.06
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
344
0.96
0.05
1.3
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
161
0.93
0.05
4.1
3.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
278
1.05
0.04
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
479
1.03
0.03
3.5
2.9
ug/l
0.8
0.7
0.20
33
294
(3019832) Treponema pallidum Ab [Presence] in Serum
22
211
1.05
0.03
1.6
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
118
0.93
0.03
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
118
0.93
0.03
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
118
0.93
0.03
1.3
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
132
1.06
0.02
1.1
1.2
—
2.5
—
0
11
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
334
3350
0.99
0.02
4.0
4.0
mmol/l
1.3
1.3
0.10
316
3068
(40761535) Cells panel - Urine sediment
28
288
0.97
0.02
3.3
3.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
46
453
1.02
0.01
3.3
2.3
%
21.3
22.7
0.22
38
390
(4094501)
10
101
0.99
0.00
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
261
1.00
0.00
1.5
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
95
1.05
0.00
1.5
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
617
1.01
0.00
1.3
1.3
u/ml
4.0
10.8
1.25
19
237
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
80
796
1.01
0.00
5.2
4.7
ug/l
2.9
2.5
0.23
73
716
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
216
1.02
0.00
1.5
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.4
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
60.3
—
0
5
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
4.8
—
6.7
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
22.6
—
0
8
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
60
1.00
0.00
1.7
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.0
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
38.7
—
0
6
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
1.6
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
79
1.01
0.00
6.6
3.1
mmol/l
1.5
1.6
—
8
79
(3006576) Bicarbonate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
6.4
—
26.2
—
0
7
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
119.2
—
0
6
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
168.5
—
0
6
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
78
0.90
0.00
1.7
1.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
87
0.92
0.00
1.5
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
59
0.85
0.00
9.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
60
1.00
0.00
1.7
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
84
0.95
0.00
1.8
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
90.7
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHAPPEND and mortality.

Females

Parameter HR [95% CI] p-value
K11_OTHAPPEND 1.183 [0.87, 1.6] 0.277
Birth year 0.996 [0.99, 1.0] 0.385

During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 525 females with K11_OTHAPPEND died.

Males

Parameter HR [95% CI] p-value
K11_OTHAPPEND 1.303 [0.91, 1.86] 0.142
Birth year 0.989 [0.98, 1.0] 0.026

During the follow-up period (1.1.1998 — 31.12.2019), 64 out of 371 males with K11_OTHAPPEND died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHAPPEND.

N-year risk Females Males
1 0.09% 0.251%
5 0.711% 1.634%
10 1.591% 4.017%
15 3.205% 7.607%
20 6.275% 13.089%

Relationships between endpoints

↥

Index endpoint: K11_OTHAPPEND – Other diseases of appendix

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data